Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
about
Clinical validity and utility of genetic risk scores in prostate cancerImproved prediction of complex diseases by common genetic markers: state of the art and further perspectivesThe role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision makingReclassification of genetic-based risk predictions as GWAS data accumulate.Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance.Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.A review of cancer risk prediction models with genetic variants.Prostate cancer in young men: an important clinical entity.Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsyCharacterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk predictionA genetic-based approach to personalized prostate cancer screening and treatment.Interest in genomic SNP testing for prostate cancer risk: a pilot survey.High SEPT9_i1 protein expression is associated with high-grade prostate cancersInfluence of age on predictiveness of genetic risk score for prostate cancer in a Chinese hospital-based biopsy cohort.Effects of EZH2 promoter polymorphisms and methylation status on oral squamous cell carcinoma susceptibility and pathology.Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancerAssessing the Cumulative Contribution of New and Established Common Genetic Risk Factors to Early-Onset Prostate Cancer.Prostate cancer risk-associated genetic markers and their potential clinical utilityPopulation-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.Incorporation of detailed family history from the Swedish Family Cancer Database into the PCPT risk calculatorVariation in predictive ability of common genetic variants by established strata: the example of breast cancer and age.Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.Risk Prediction Using Genome-Wide Association Studies on Type 2 Diabetes.Prediction of Quantitative Traits Using Common Genetic Variants: Application to Body Mass Index.Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Multigene panels in prostate cancer risk assessment: a systematic review.Prediction of individual genetic risk to prostate cancer using a polygenic score.Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men.MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project.Utility of single nucleotide polymorphisms in prostate biopsy decisions
P2860
Q26746219-44587D63-CB7F-4C89-8799-CD4609EDD25EQ26770167-88CBB7A4-6B2A-42EA-B759-59D033D03B94Q27025062-A429DE87-9558-49E8-9088-D80C20EE534FQ31046674-2102516A-CBF3-4A9C-BDFB-F1515E34E545Q33863654-51A51B3A-67C9-4E52-A234-7CF3C6EB8054Q33883502-B7006DE8-632F-4FF2-9CCC-59A02600348AQ34265269-C52EA812-021E-4BDA-B6C6-6F789C3A62C5Q34314644-49A3DBE5-7597-4496-9DD4-B743C7D1BE8BQ34323314-3A59F7F3-D2BA-47B8-B56C-8FBCD1F58AF2Q34661857-835A2109-E433-4CCB-A5FC-DB7EDE18506BQ34802764-0ADBC884-F12F-4A64-873A-BAF490916246Q35403712-876C6178-AF45-4DA3-AB8C-A4BF57ADE7C7Q35610801-9EE4B031-89F0-47F5-A30D-929346EBBAF8Q36356134-EBEB3BD1-2EDD-41B8-BBB5-7AFC0E80A1F7Q36420195-255B8E75-5105-45CA-925B-551669193F5EQ36545434-DF68BD0F-122D-4E6B-A9D8-9A789985AA29Q36918140-BE616488-3198-45D4-85BC-4E0A5DAF8CC9Q37085446-667B2012-B967-4A79-B4FF-8898FABCD968Q37113165-1B4D8D26-2954-4A67-9DF5-8785E280550BQ37279076-E1ABEB92-9C65-4BAF-8981-9C71FF35EBB1Q37370221-2CEF7524-AABB-464A-9BB1-CAABDF18776AQ37541989-0C322A05-AAFE-4D77-BD5F-FD231EE5F6BAQ37618965-CF5BDD0C-73F7-4BA4-8F83-FF0B1C7C65B9Q37618968-2F0792A2-B56E-4F74-BB8C-0BDA8596A198Q37735483-0E7BBC9A-7AF5-4146-BE8E-E81CA5622C28Q38596777-F37A2726-E9EA-4C5D-9ADD-847764160F96Q41584352-D0389FC2-7719-4781-AD88-BB6F2B04470DQ46777345-4FFA4D2D-CB07-44C9-BA4F-D335A6096FC5Q54938332-E7DAF592-6DD1-4011-8617-22BE88B973ABQ58047218-58C129AE-9D94-4505-95DD-BCC112AAAAB9
P2860
Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Common genetic variants in pro ...... ancer Cohort Consortium (BPC3)
@ast
Common genetic variants in pro ...... ancer Cohort Consortium (BPC3)
@en
type
label
Common genetic variants in pro ...... ancer Cohort Consortium (BPC3)
@ast
Common genetic variants in pro ...... ancer Cohort Consortium (BPC3)
@en
prefLabel
Common genetic variants in pro ...... ancer Cohort Consortium (BPC3)
@ast
Common genetic variants in pro ...... ancer Cohort Consortium (BPC3)
@en
P2093
P2860
P50
P1476
Common genetic variants in pro ...... ancer Cohort Consortium (BPC3)
@en
P2093
Carlos A Gonzalez
Daniel O Stram
E David Crawford
Gerald Andriole
J Michael Gaziano
Laurence N Kolonel
Meir Stampfer
Michael J Thun
Naomi E Allen
P2860
P304
P356
10.1158/1055-9965.EPI-11-1038
P50
P577
2012-01-11T00:00:00Z